Medical versus surgical abortion methods for pregnancy in China: a cost-minimization analysis

Gynecol Obstet Invest. 2011;72(4):257-63. doi: 10.1159/000328313. Epub 2011 Oct 13.

Abstract

Background: Both medical and surgical abortions are popular in developing countries. However, the monetary costs of these two methods have not been compared.

Methods: 430 women seeking abortions were recruited in 2008. Either a medical or surgical method was used for the abortion. We adopted the perspective of a third-party payer. Cost-minimization analysis was used based on all charges for the overall procedures in an out-patient clinic in Guangzhou, China.

Results: 219 subjects (51%) chose a medical method (mifepristone and misoprostol), whereas 211 subjects (49%) chose a surgical method. The efficacy in the surgical group was significantly higher than in the medical group (100 vs. 90%, p < 0.001). Surgical abortion incurred much more costs than medical abortion on average after initial treatment. When the subsequent costs were accumulated within the 2-week follow-up, the mean total cost in the medical group increased significantly due to failure of abortion and persistent bleeding. Patients undergoing medical abortion eventually incurred equivalent expenses compared to patients undergoing surgical abortion (p = 0.42).

Conclusions: There was no difference in the mean final costs between the two abortion methods. Complications of persistent bleeding and failure to abort (requiring surgical intervention) in the medical treatment group increased the final mean total cost substantially.

Publication types

  • Comparative Study

MeSH terms

  • Abortifacient Agents / adverse effects
  • Abortifacient Agents / economics*
  • Abortion, Induced / adverse effects
  • Abortion, Induced / economics
  • Abortion, Induced / methods*
  • Adolescent
  • Adult
  • China
  • Cost-Benefit Analysis
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Mifepristone / adverse effects
  • Mifepristone / economics*
  • Misoprostol / adverse effects
  • Misoprostol / economics*
  • Pregnancy
  • Treatment Outcome
  • Vacuum Curettage / adverse effects
  • Vacuum Curettage / economics*
  • Young Adult

Substances

  • Abortifacient Agents
  • Misoprostol
  • Mifepristone